Drug intelligence / Profile preview

Tiaojing Quban Tablets

Development stage: Unknown
Lead developer: Hefei Huafang Pharmaceutical Technology
Administration: Oral

Overview

Tiaojing Quban Tablets (调经祛斑片) is a Traditional Chinese Medicine (TCM) formulation developed and manufactured by Hefei Huafang Pharmaceutical Technology. It is approved in China for the treatment of irregular menstruation and facial melasma (chloasma). The therapeutic approach of the tablets is rooted in TCM principles of nourishing the blood, regulating menstrual cycles, and promoting blood circulation to resolve stasis. By addressing underlying qi and blood deficiencies and hormonal disharmony, the drug aims to reduce skin pigmentation and restore menstrual regularity. It is typically administered orally as a multi-herb extract combination.

Brand names: Tiaojing Quban Tablets调经祛斑片
Other names: Tiaojing Quban Pian调经祛斑片

Beyond the preview

Go deeper on Tiaojing Quban Tablets.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tiaojing Quban Tablets.

Explore the full profile